Chatbot help for lung cancer side effects
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a LINE chatbot that helps lung cancer patients manage side effects from targeted therapy pills. It might help you feel more in control of your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced lung cancer (stage IIIB to IVB) that cannot be removed with surgery, or it has come back after treatment.
- You are taking one of these oral targeted therapy pills: gefitinib, erlotinib, afatinib, dacomitinib, or osimertinib.
- You are able to take care of yourself (you are up and about more than half of the day).
- You can read and write in Chinese, and you can use a smartphone to chat on LINE.
- You are willing to sign a consent form to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether using WeChat (a messaging app) to communicate with your healthcare team can improve survival and quality of life for people with lung cancer. If you join, your care team will keep in touch with you through WeChat to provide support and education.
This study uses a mobile internet platform (WeChat) to check on how patients are doing after lung cancer surgery. It aims to improve your recovery and quality of life by collecting updates on your health.
This study tests a smartphone-based program to help people with advanced lung cancer manage their symptoms and daily life. The program uses WhatsApp or WeChat to provide support and aims to improve quality of life.
This study tests a chatbot that offers support and advice for cancer survivors. If you're a young adult dealing with symptoms or side effects, this could help you manage them better.
This study tests a brief mindfulness program delivered through a chatbot on the LINE app. It may help reduce stress and improve well-being for people with cancer.
This study tests a personalized discharge education program using AI to help patients recover at home after lung cancer surgery. The goal is to improve recovery by giving tailored instructions and support.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.